Ancora Advisors LLC increased its stake in Cerner Co. (NASDAQ:CERN) by 77.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,190 shares of the company’s stock after acquiring an additional 5,325 shares during the period. Ancora Advisors LLC’s holdings in Cerner were worth $785,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Janney Montgomery Scott LLC raised its holdings in shares of Cerner by 5.2% in the second quarter. Janney Montgomery Scott LLC now owns 28,329 shares of the company’s stock valued at $1,694,000 after buying an additional 1,400 shares during the last quarter. TD Asset Management Inc. raised its holdings in shares of Cerner by 16.8% in the second quarter. TD Asset Management Inc. now owns 242,508 shares of the company’s stock valued at $14,500,000 after buying an additional 34,794 shares during the last quarter. CWM LLC raised its holdings in shares of Cerner by 880.5% in the second quarter. CWM LLC now owns 2,510 shares of the company’s stock valued at $150,000 after buying an additional 2,254 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. raised its holdings in shares of Cerner by 6.3% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 915,983 shares of the company’s stock valued at $54,767,000 after buying an additional 54,528 shares during the last quarter. Finally, Aviva PLC raised its holdings in shares of Cerner by 8.7% in the second quarter. Aviva PLC now owns 159,740 shares of the company’s stock valued at $9,551,000 after buying an additional 12,734 shares during the last quarter. Institutional investors own 77.70% of the company’s stock.
CERN has been the subject of a number of research analyst reports. Royal Bank of Canada cut Cerner from an “outperform” rating to a “sector perform” rating and cut their price target for the company from $72.00 to $54.00 in a report on Friday, October 26th. Zacks Investment Research cut Cerner from a “hold” rating to a “sell” rating in a report on Monday, October 8th. BidaskClub cut Cerner from a “hold” rating to a “sell” rating in a report on Friday, August 31st. Leerink Swann raised Cerner from a “market perform” rating to an “outperform” rating and set a $70.00 price target for the company in a report on Monday, October 29th. Finally, Barclays initiated coverage on Cerner in a report on Thursday, September 13th. They issued an “equal weight” rating and a $70.00 price target for the company. One analyst has rated the stock with a sell rating, nine have issued a hold rating and eleven have issued a buy rating to the company. Cerner presently has an average rating of “Hold” and an average target price of $69.86.
Shares of NASDAQ:CERN opened at $58.11 on Tuesday. The stock has a market cap of $19.08 billion, a price-to-earnings ratio of 26.41, a PEG ratio of 1.89 and a beta of 0.96. Cerner Co. has a 1-year low of $50.91 and a 1-year high of $73.43. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.63 and a quick ratio of 2.60.
Cerner (NASDAQ:CERN) last announced its quarterly earnings data on Thursday, October 25th. The company reported $0.57 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.58 by ($0.01). The firm had revenue of $1.34 billion for the quarter, compared to the consensus estimate of $1.36 billion. Cerner had a return on equity of 14.73% and a net margin of 15.72%. As a group, sell-side analysts expect that Cerner Co. will post 2.22 EPS for the current year.
Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Further Reading: Quiet Period
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.